The PaceNew therapies / indications available since the last 12 months 
LINAGLIPTIN TAISHO®
BY: Dr. Feng XueJun 13, 2025

LINAGLIPTIN TAISHO®
(linagliptin)
TAISHO
HK Reg. No. HK-68588 (26 Feb, 2025)
Composition:2

• Linagliptin is available as 5 mg oral tablets
 

Indication:2

• Linagliptin is used with diet and exercise to help lower blood sugar levels in people with type 2 diabetes. Linagliptin works by inhibiting dipeptidyl peptidase-4 enzyme (DPP-4)

 

References

2. WebMD. Linagliptin (Tradjenta) - Uses, Side Effects, and More. 12 June 2024. Available from: https://www.webmd.com/drugs/2/drug-155816/linagliptin-oral/details. [Accessed 16 May 2025].

 

You May Be Interested In
INVEGA HAFYERA
BY: Winnie TangFeb 6, 2024
Humira®
BY: Jasper ChanMar 18, 2022
Iclusig
BY: Olive TseDec 16, 2019
Rexulti
BY: Olive TseMar 16, 2020